Home LiteratureArticle Details
PMID: 2079448 Published · ppublish English Comparative Study Journal Article

In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.

The Journal of antimicrobial chemotherapy ·Vol. 26 ·No. 5 ·1990-11-00 ·Pages 659-66

Tanaka M, Otsuki M, Une T, Nishino T

Abstract

DR-3355 [S-(-)-ofloxacin], an optically active isomer of ofloxacin, showed a broad spectrum of antibacterial activity against both Gram-positive and Gram-negative bacteria and was generally twice as potent as ofloxacin and considerably more active than DR-3354 [R-(+)-ofloxacin]. The activity of DR-3355 was largely unaffected by the type of culture medium, inoculum size and addition of human serum, but decreased under acidic condition at pH 6.0. The protective effect of orally administered DR-3355 in experimental infections in mice with various bacterial pathogens was superior to those of ofloxacin and ciprofloxacin.

MeSH Terms
Animals Bacteria/drug effects Bacterial Infections/drug therapy,microbiology Ciprofloxacin/pharmacology,therapeutic use Culture Media Hydrogen-Ion Concentration Isomerism Male Mice Mice, Inbred Strains Microbial Sensitivity Tests Ofloxacin/pharmacology,therapeutic use
Chemicals
Culture Media Ciprofloxacin Ofloxacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Tanaka M
Department of Microbiology, Kyoto Pharmaceutical University, Japan.
Otsuki M
Une T
Nishino T
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1990-11-00
Pages
659-66
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]